trial_id,number_of_countries,min_end_date,max_end_date,comp_date,has_results,includes_pip,single_blind,rare_disease,phase,bioequivalence_study,health_volunteers,trial_status,terminated,results_expected,all_completed_no_comp_date,sponsor_status,name_of_sponsor,trial_title,trial_url,comp_date_while_ongoing
2004-000406-99,7,2007-05-31,2007-05-31,3,1,0,0,0,2,0,0,2,0,0,0,1,"unmatched","A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of S...",https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-000406-51,1
2004-000028-34,4,2008-03-10,2008-03-10,2,0,0,0,0,3,0,0,1,0,1,0,1,Lilly S.A,A randomised Phase 3 Trial of ALIMTA and Cisplatin versus GEMZAR and Cisplatin in Patients with locally advanced or metastatic Non-Small-Cell Lung Cancer,https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-000028-34,0
